20642 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs; Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
Mast Cell Stabilizers to Prevent or Treat Laminitis
#602Methods of mammalian retinal stem cell production and applications
#603TISSUE EXTRACELLULAR MATRIX PARTICLES AND APPLICATIONS
#604Formulation, apparatus, and methods for treatment of brain trauma
#605Markers for differentiation of stem cells into differentiated cell populations
#606Method for improving efficiency of inducing pluripotent stem cell
#607Method for enhancing therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases
#608Biomolecular group related to cell anti-aging
#609Induced hepatocytes and uses thereof
#610METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
#611NOVEL METHOD
#612Process for enhancing stem cell bioactivity using tauroursodeoxycholic acid
#613Patient-specific stem cell lines derived from human parthenogenetic blastocysts
#614Stem cells for modeling type 2 diabetes
#615THERAPEUTIC OZONE AGENT AND TREATMENT
#616Protein biomaterials and biocoacervates and methods of making and using thereof
#617GYNOGENETIC OR ANDROGENETIC PRODUCTION OF PLURIPOTENT CELLS AND CELL LINES, AND USE THEREOF TO PRODUCE DIFFERENTIATED CELLS AND TISSUES
#618Methods for inducing partial apoptosis using caspase polypeptides
#619Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC)
#620Compositions and methods for reprograming non-pluripotent cells into pluripotent stem cells
#621Method for cellular restoration
#622Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
#623Method for producing renal progenitor cells
#624GENERATION OF MALE GERM CELLS
#625CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
#626IL-12 immunotherapy for cancer
#627Chemical differentiation of pluripotentstem cells into retinal epithelial cells
#628Method for enhancing therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases
#629PLURIPOTENT STEM CELL FOR TREATMENT OF CHRONIC KIDNEY DISEASE
#630Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
#631Bioengineered allogeneic blood vessel
#632Compositions and Methods for Improving the Functional Efficacy of Stem Cell-Derived Cardiomyocytes
#633Compositions and methods for immunotherapy
#634Cell sorting method
#635METHODS AND SYSTEMS FOR TREATING ISCHEMIC TISSUES
#636Method of deriving mature hepatocytes from human embryonic stem cells
#637Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis
#638Methods of using ZSCAN4 for rejuvenating human cells
#639PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS
#640Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
#641Somatic stem cells
#642Method Of Using Mitotically Inactivated Stem Cells For Damaged Tissue Repair
#643HUMAN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS FOR TREATMENT OF OCULAR DISEASE
#644Methods and compositions for the treatment and/or prevention of type 1 diabetes
#645STEM CELL COMPOSITIONS AND METHODS FOR WOULD HEALING
#646METHODS OF IMPROVING CELL-BASED THERAPY
#647Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury
#648Compositions and methods for modulation of SMN2 splicing in a subject
#649Preparing tooth-like structure using stem cell
#650Composition for treating inflammatory brain diseases which includes stem cell as active ingredient
#651Minimal volume reprogramming of mononuclear cells
#652Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#653Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#654Methods for inducing selective apoptosis
#655Growth matrices for stem cell propagation in vitro and in tissue regeneration
#656Extracellular matrix (ECM) structures for tissue regeneration
#657Methods to rebalance the hypothalamic-pituitary-gonadal axis
#658Mast cell stabilizers to prevent or treat laminitis
#659iPS/ES CELL-SPECIFIC ANTIBODY HAVING CYTOTOXICITY TO TARGET CELLS AND USE THEREOF
#660Method and system for generation and use of activated stem cells
#661METHODS AND COMPOSITIONS FOR TREATING DIABETES WITH IPS DERIVED PANCREATIC BETA-LIKE CELLS
#662Extracellular matrix derived from stem cells and methods for production
#663METHODS AND COMPOSITIONS USING FGF-9 TO ENHANCE NEOVASCULARIZATION AND REGENERATION
#664Method of using mitotically inactivated stem cells for damaged tissue repair
#665MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE
#666METHOD FOR INDUCING CELLS TO LESS MATURE STATE
#667CRYOPRESERVATION OF CELLS INSIDE A MACRO-ENCAPSULATION DEVICE
#668Method for inducing pluripotent stem cells to differentiate into ventricular myocytes in vitro
#669CANCER-SPECIFIC SUICIDE GENE FOR CELL-BASED AND GENE THERAPY
#670Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
#671INHIBITION OF RHO AND OR ROCK AND CELL TRANSPLANTATION
#672Inorganically surface-modified polymers and methods for making and using them
#673Sulfated alginate hydrogels for cell culture and therapy
#674Methods of capturing tumor cells
#675Placental Stem Cells Derived From Post-Partum Mammalian Placenta, And Uses And Methods Of Treatment Using Said Cells
#676Methods of reprogramming chondrocytes
#677Artificial skeletal material and constructs formed therefrom
#678TISSUE TRANSPLANT COMPOSITIONS AND METHODS FOR USE
#679Method of providing cellular therapy using modified natural killer cells or T lymphocytes
#680Compositions for regenerating defective or absent myocardium
#681Compositions for regenerating defective or absent myocardium
#682CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
#683Urine stem cells for skeletal muscle generation and uses thereof
#684METHODS OF PREPARING PLURIPOTENT STEM CELLS
#685Compositions for regenerating defective or absent myocardium
#686Method of creating hydrogels through oxime bond formation
#687Compositions suitable for treatment of spinal disease, disorder or condition
#688Use of des-aspartate-angiotensin I in inflammation-related pathologies and diseases
#689Methods and compositions for treatment of penile defects
#690Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells
#691Compounds that enhance Atoh1 expression
#692High-throughput image-based chemical screening in zebrafish blastomere cell culture
#693Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
#694COMPOSITIONS AND METHODS FOR PREVENTING ALLOGENEIC IMMUNE REJECTION
#695Compositions and methods for inducing thrombopoiesis
#696Gene targeting methods and tools
#697NOVEL STEM CELLS, NUCLEOTIDE SEQUENCES AND PROTEINS THEREFROM
#698Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation
#699IMMUNE MODULATION BY PERI-LYMPHATIC OR INTRA-LYMPHATIC CELL THERAPY
#700OCULAR THERAPEUTICS USING EMBRYONIC STEM CELL MICROVESICLES
#701Method for blocking tumour growth
#702HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof
#703METHODS AND COMPOSITIONS USING FGF-8 TO ENHANCE CARDIAC REGENERATION AND ATTENUATE ADVERSE CARDIAC REMODELING
#704PLURIPOTENT STEM CELLS AND METHOD OF STIMULATING AND EXTRACTING NON-EMBRYONIC PLURIPOTENT STEM CELLS FROM MAMMAL BLOOD AND USING RECONSTITUTED PLURIPOTENT STEM CELLS TO TREAT DISEASES INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#705Brain-specific enhancers for cell-based therapy
#706Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues
#707Embryonic stem cell specific microRNAs promote induced pluripotency
#708In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
#709Bioengineered allogeneic blood vessel
#710Modalities for the treatment of degenerative diseases of the retina
#711Self-assembled composite ultrasmall peptide-polymer hydrogels
#712Image guided protocol for cell generation
#713Methods of using ZSCAN4 for rejuvenating human cells
#714CELL THERAPY FOR MYELODYSPLASTIC SYNDROMES
#715Method for preparing mesenchymal stem cell-like cells and cardiomyocyte-like cells
#716Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases
#717Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming
#718Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
#719Modalities for the treatment of degenerative diseases of the retina
#720Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
#721Method for producing tissue and organ
#722METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#723Uses of indole-ketones or indolidones as neuro-protective drugs
#724Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells
#725Cell secreted proteins for the treatment of myocardial infarction
#726Compositions for regenerating defective or absent myocardium
#727MICROVESICLES ISOLATED FROM MESENCHYMAL STEM CELLS FOR USE AS IMMUNOSUPPRESSIVE AGENTS
#728Compositions for Regenerating Defective or Absent Myocardium
#729Desiccated biologics and methods of preparing the same
#730Production of dentin, cementum and enamel by cells
#731Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#732Method of isolating human embryonic stem cells in minimal essential medium
#733Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
#734Method for storing a preparation of human embryonic stem cells
#735Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
#736Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
#737Treatment of immunosuppression-related disorders
#738Therapeutic compositions and methods
#739Modalities for the treatment of degenerative diseases of the retina
#740Modalities for the treatment of degenerative diseases of the retina
#741METHOD FOR STEM CELL DIFFERENTIATION IN VIVO BY DELIVERY OF MORPHOGENES WITH MESOPOROUS SILICA AND CORRESPONDING PHARMCEUTICAL ACTIVE INGREDIENTS
#742Modalities for the treatment of degenerative diseases of the retina
#743Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
#744Modalities for the treatment of degenerative diseases of the retina
#745Modalities for the treatment of degenerative diseases of the retina
#746Method for developing natural killer cells from stem cells
#747Compositions for regenerating defective or absent myocardium
#748HUMAN INDUCED PLURIPOTENT STEM CELLS
#749STABLE REPROGRAMMED CELLS
#750TREATMENT OF DIABETES USING G-CSF AND HYPERBARIC OXYGEN
#751COMPOSITIONS OF CELLS, MEDIA, AND METHODS THEREOF
#752Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells
#753Method of deriving mature hepatocytes from human embryonic stem cells
#754Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune disorders and inflammatory diseases
#755REGULATION OF GLYPICAN 4 ACTIVITY TO MODULATE THE FATE OF STEM CELLS AND USES THEREOF
#756ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#757Acellular bioabsorbable tissue regeneration matrices
#758Compositions for regenerating defective or absent myocardium
#759Pluripotent cells
#760Method of partially differentiating hES cells
#761Compositions for regenerating defective or absent myocardium
#762Use of des-aspartate-angiotensin I in inflammation-related pathologies and diseases
#763Methods For Increasing Blood Flow And/Or Promoting Tissue Regeneration
#764Stem cell secreted product derived compositions for wound treatment
#765Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
#766Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells in Fibromodulin
#767METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#768Pharmaceutical compositions and methods for the treatment and prevention of cancer
#769STEM CELL BANK FOR PERSONALIZED MEDICINE
#770Catheter-Based Delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
#771PLURIPOTENT STEM CELLS AND METHOD OF STIMULATING AND EXTRACTING NON-EMBRYONIC PLURIPOTENT STEM CELLS FROM MAMMAL BLOOD AND USING RECONSTITUTED PLURIPOTENT STEM CELLS TO TREAT DISEASES INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#772Modalities for the treatment of degenerative diseases of the retina
#773Myogenic differentiation of stem cells and uses thereof
#774Compounds that enhance Atoh1 expression
#775Primed stem cells and uses thereof to treat inflammatory conditions in joints
#776METHOD AND COMPOSITION FOR SKIN CARE COMPRISING CORD BLOOD SERUM OR PLASMA OR COMPONENTS THEREOF
#777Wound treatments with crosslinked protein amorphous biomaterials
#778Anti-HIV group I introns and uses thereof in treating HIV infections
#779Regenerative materials
#780PLATELET SOLUTION FOR USE IN JOINT SURGERY
#781TISSUE TRANSPLANT COMPOSITIONS AND METHODS FOR USE
#782Methods for reprogramming cells and uses thereof
#783Human embryonic stem cell methods and PODXL expression
#784Stem cells, nucleotide sequences and proteins therefrom
#785COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF
#786Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#787THIN SHELL GRAFT FOR CARTILAGE RESURFACING
#788Methods for treating inhalation injury
#789TREATMENT OF ACNE BY CONDITIONED MEDIA
#790Topical skin care compositions and methods
#791Hydrogel bioscaffold and coating for bone and tooth repair
#792Treating cardiovascular tissue
#793MICROVESICLES DERIVED FROM NUCLEATED, MAMMALIAN CELLS AND USE THEREOF
#794Personalized production of biologics and method for reprogramming somatic cells
#795DIFFERENTIALLY METHYLATED REGIONS OF REPROGRAMMED INDUCED PLURIPOTENT STEM CELLS, METHOD AND COMPOSITIONS THEREOF
#796INTRACORONARY DEVICE AND METHOD OF USE THEREOF
#797Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa
#798Intracoronary device and method of use thereof
#799Methods for complex tissue engineering
#800INTRACORONARY DEVICE AND METHOD OF USE THEREOF
#801PERICYTE PROGENITOR CELLS AND METHODS OF GENERATING AND USING SAME
#802COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS
#803Method for treating damaged tissue of the CNS
#804USE OF CATALYTIC ANTIOXIDANT TO PRESERVE STEM CELL PHENOTYPE AND CONTROL CELL DIFFERENTIATION
#805Embryonic stem cell specific microRNAs promote induced pluripotency
#806Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
#807Methods and compositions for inhibiting viral entry into cells
#808TREATMENT OF DIABETES USING G-CSF AND HYPERBARIC OXYGEN
#809IMPLANTABLE BIOREACTOR FOR DELIVERY OF PARACRINE FACTORS
#810Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors
#811STEM CELLS FOR MUSCULOSKELETAL TISSUE REPAIR
#812Intracoronary Device And Method Of Use Thereof
#813Tissue repair with multipotent cells
#814MICROORGANISMS FOR PREVENTING AND TREATING NEOPLASMS ACCOMPANYING CELLULAR THERAPY
#815PLACENTAL STEM CELLS DERIVE FROM POST-PARTUM MANMALIAN PLACENTA, AND USES AND METHODS OF TREATMENT USING SAID CELLS
#816EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION
#817Bone marrow targeting peptides
#818THERAPEUTIC ENCAPSULATED EMBRYONIC STEM CELLS AND MESENCHYMAL STROMAL CELLS
#819MHC-Less cells
#820Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
#821Inorganically surface-modified polymers and methods for making and using them
#822Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
#823VENTRICULAR INDUCED PLURIPOTENT STEM (ViPS) CELLS FOR GENERATION OF AUTOLOGOUS VENTRICULAR CARDIOMYOCYTES AND USES THEREOF
#824Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
#825Modulation of splenocytes in cell therapy
#826Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
#827Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
#828Use of Stem Cells to Prevent Neuronal Dieback
#829Methods for inducing selective apoptosis
#830Differentiation of human embryonic stem cells
#831ENTRAPPED STEM CELLS AND USES THEREOF
#832Hepatic progenitor cells and uses thereof
#833CD34 Stem Cell-Related Methods and Compositions
#834Preparation method of porous hyaluronic acid sponge for cell delivery system
#835Method for treating or preventing a pancreatic dysfunction
#836METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#837COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY
#838Uses and isolation of stem cells from bone marrow
#839ADULT BONE MARROW CELL TRANSPLANTATION TO TESTES CREATION OF TRANSDIFFERENTIATED TESTES GERM CELLS, LEYDIG CELLS AND SERTOLI CELLS
#840SKIN AND HAIR CARE USING EXTRACT FROM CONDITIONED MEDIUM CULTURED BY MESENCHYMAL STEM CELLS AND OTHER REGENERATIVE CELLS
#841Concurrent delivery of multiple therapeutic agents via hydrogels for biomedical applications
#842METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#843Derivation of embryonic stem cells
#844Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
#845Episomal reprogramming with chemicals
#846Desiccated biologics and methods of preparing the same
#847Methods, Systems, and Apparati for Cellular Therapeutic Agent Preparation and Delivery
#848POROUS SCAFFOLDS FOR STEM CELL RENEWAL
#849MICROORGANISMS FOR PREVENTING AND TREATING NEOPLASMS ACCOMPANYING CELLULAR THERAPY
#850Desiccated Biologics And Methods Of Preparing The Same
#851METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#852Use of Stem Cells to Reduce Leukocyte Extravasation
#853USE OF HUMAN STEM CELLS AND/OR FACTORS THEY PRODUCE TO PROMOTE ADULT MAMMALIAN CARDIAC REPAIR THROUGH CARDIOMYOCYTE CELL DIVISION
#854MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#855WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors
#856Compositions suitable for treatment of spinal disease, disorder or condition
#857IL-12 immunotherapy for cancer
#858PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES
#859Intrathecal administration of autologous stem cells to treat intraventricular hemorrhage in premature infants
#860Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
#861Modulating bone growth in treating scoliosis
#862Treatment of immunosuppression-related disorders
#863Methods of generating, repairing and/or maintaining connective tissue in vivo
#864Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs)
#865Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery
#866Stem cell secreted product derived compositions for wound treatment
#867Embryonic-like stem cells derived from adult human peripheral blood and methods of use
#868Cell Delivery System to Induce Cell Growth and Angiogenesis
#869Polymer coating of cells
#870Somatic cells for use in cell therapy
#871MESOANGIOBLAST-LIKE CELL AS WELL AS METHODS AND USES RELATING THERETO
#872METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#873Treatment of Injuries to the Central Nervous System
#874METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION
#875Treatment of disc degenerative disease
#876MAPC therapeutics without adjunctive immunosuppressive treatment
#877METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#878Alginate polyelectrolyte encapsulation of embryonic stem cells
#879Treatment of erectile dysfunction by stem cell therapy
#880TREATMENT SYSTEMS AND METHODS FOR RENAL-RELATED DISEASES
#881Mast cell stabilizers to prevent or treat laminitis
#882Pluripotent cells
#883HUMAN CORD BLOOD DERIVED UNRESTRICTED SOMATIC STEM CELLS (USSC)
#884Composition for delivery of hematopoietic growth factor
#885Compounds that enhance Atoh1 expression
#886Methods And Materials For Immunization Against Cancer
#887Cardiac tissue repair by mitotically inactivated pluripotent and/or embryonic stem cells
#888Human embryonic stem cell methods and PODXL expression
#889Method of reducing blood glucose levels in type 2 diabetes patients by administering granulocyte-colony stimulating factor
#890Extracellular Matrix Compositions for Tissue Regeneration
#891Methods and systems for treating ischemic tissues
#892Chondrocyte Differentiation from Human Embryonic Stem Cells and Their Use in Tissue Engineering
#893Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
#894Attenuated reoviruses for selection of cell populations
#895Mobilization of Stem Cells After Trauma and Methods Therefor
#896Desiccated Biologics And Methods Of Preparing The Same
#897Stem cells, nucleotide sequences and proteins therefrom
#898ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#899CD34 stem cell-related methods and compositions
#900COMBINATION OF INTERLEUKIN-6 ANTAGONISTS AND ANTIPROLIFERATIVE DRUGS